TherapeuticsMD's BIJUVA now available in U.S.

|About: TherapeuticsMD, Inc. (TXMD)|By:, SA News Editor

TherapeuticsMD (NASDAQ:TXMD) announces the commercial availability of BIJUVA (estradiol and progesterone capsules, 1 mg/100 mg) in U.S.

BIJUVA is the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus.

The Company plans to hold an Investor Day in New York on June 10.

Shares are up 7% premarket.

Subscribe for full text news in your inbox